Response Genetics Stock Alpha and Beta Analysis

RGDXQ Stock  USD 0.0001  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Response Genetics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Response Genetics over a specified time horizon. Remember, high Response Genetics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Response Genetics' market risk premium analysis include:
Beta
0.0
Alpha
0.0
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although Response Genetics alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Response Genetics did 0.00  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Response Genetics stock's relative risk over its benchmark. Response Genetics has a beta of 0.00  . The returns on DOW JONES INDUSTRIAL and Response Genetics are completely uncorrelated. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Response Genetics Backtesting, Response Genetics Valuation, Response Genetics Correlation, Response Genetics Hype Analysis, Response Genetics Volatility, Response Genetics History and analyze Response Genetics Performance.

Response Genetics Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Response Genetics market risk premium is the additional return an investor will receive from holding Response Genetics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Response Genetics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Response Genetics' performance over market.
α0.00   β0.00

Response Genetics expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Response Genetics' Buy-and-hold return. Our buy-and-hold chart shows how Response Genetics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Response Genetics Market Price Analysis

Market price analysis indicators help investors to evaluate how Response Genetics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Response Genetics shares will generate the highest return on investment. By understating and applying Response Genetics pink sheet market price indicators, traders can identify Response Genetics position entry and exit signals to maximize returns.

Response Genetics Return and Market Media

The median price of Response Genetics for the period between Thu, Sep 25, 2025 and Wed, Dec 24, 2025 is 1.0E-4 with a coefficient of variation of 0.0. The daily time series for the period is distributed with a sample standard deviation of 0.0, arithmetic mean of 0.0, and mean deviation of 0.0. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  

About Response Genetics Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Response or other pink sheets. Alpha measures the amount that position in Response Genetics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Response Genetics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Response Genetics' short interest history, or implied volatility extrapolated from Response Genetics options trading.

Build Portfolio with Response Genetics

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Response Pink Sheet Analysis

When running Response Genetics' price analysis, check to measure Response Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Response Genetics is operating at the current time. Most of Response Genetics' value examination focuses on studying past and present price action to predict the probability of Response Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Response Genetics' price. Additionally, you may evaluate how the addition of Response Genetics to your portfolios can decrease your overall portfolio volatility.